-
Amazon's PillPack Acquisition: What It Means For The Tech Giant And Everybody Else
Friday, June 29, 2018 - 12:43pm | 951Amazon.com, Inc. (NASDAQ: AMZN) announced its acquisition of PillPack, an online pharmacy previously targeted by Walmart Inc (NYSE: WMT). The transaction is seen to advance Amazon’s health care campaign to the detriment of the vast and diverse sector. What It Means For Amazon Amazon had...
-
With Rite Aid Uncertainty Behind It, Could Walgreens Go Shopping?
Monday, December 4, 2017 - 2:44pm | 465For more than two years, pharmaceutical giant Walgreens Boots Alliance Inc (NASDAQ: WBA) has been "tap dancing horizontally" with smaller rival Rite Aid Corporation (NYSE: RAD). In the end, Rite Aid agreed to sell Walgreens 1,932 of its stores in a $4.4-billion deal that now frees up...
-
Credit Suisse Reiterates Outperform, Raises Price Target On Diplomat Pharmacy On Strong 4Q Results
Tuesday, March 3, 2015 - 11:03am | 231In a report published Tuesday, Credit Suisse analyst Glen Santangelo reiterated an Outperform rating on Diplomat Pharmacy, Inc. (NYSE: DPLO), and raised the price target from $29.00 to $37.00. In the report, Credit Suisse noted, "DPLO reported F4Q EPS of $0.08 vs FactSet consensus of $0.06. The...
-
UPDATE: Credit Suisse Upgrades Laboratory Corporation Of America As Guidance Remains Interesting
Monday, February 23, 2015 - 10:15am | 175In a report published Monday, Credit Suisse analyst Glen Santangelo upgraded the rating on Laboratory Corporation of America Holdings (NYSE: LH) from Neutral to Outperform, and raised the price target from $113.00 to $140.00. In the report, Credit Suisse noted, "Since 11/3/14 when the CVD deal was...
-
UPDATE: Credit Suisse Reiterates On Sirona Dental Systems Following F4Q14 Earnings
Tuesday, December 2, 2014 - 8:38am | 119In a report published Tuesday, Credit Suisse analyst Glen Santangelo reiterated an Outperform rating on Sirona Dental Systems (NASDAQ: SIRO), and raised the price target from $90.00 to $100.00. In the report, Credit Suisse noted, “Following SIRO's F4Q14 earnings we have revisited our financial...
-
UPDATE: Credit Suisse Reiterates On Henry Schein Following 3Q14 Earnings Results
Friday, November 7, 2014 - 10:41am | 133In a report published Friday, Credit Suisse analyst Glen Santangelo reiterated a Neutral rating on Henry Schein (NASDAQ: HSIC), and raised the price target from $121.00 to $135.00. In the report, Credit Suisse noted, “We have revisited our HSIC model following the 3Q14 earnings results and...
-
Align Technology Surges 5% Amid Credit Suisse Upgrade
Monday, October 20, 2014 - 11:34am | 194Credit Suisse upgraded Align Technology, Inc. (NASDAQ: ALGN) from Neutral to Outperform with a $58 price target. Analyst Glen Santangelo noted that "following significant outperformance in 2013, shares of ALGN have lagged the broader market YTD (down ~20 percent vs. S&P up ~3 percent...
-
UPDATE: Credit Suisse Upgrades PharMerica on Outlook Infused with New Growth Drivers
Wednesday, March 12, 2014 - 8:25am | 199In a report published Wednesday, Credit Suisse analyst Glen Santangelo upgraded the rating on PharMerica Corporation (NYSE: PMC) from Neutral to Outperform, and raised the price target from $19.00 to $30.00. In the report, Credit Suisse noted, “Although shares of PMC have outperformed the market...
-
UPDATE: Credit Suisse Downgrades Weight Watchers International Ahead of Earnings Report, Investor Day
Wednesday, October 23, 2013 - 11:13am | 175In a report published Wednesday, Credit Suisse analyst Glen Santangelo downgraded the rating on Weight Watchers International (NYSE: WTW) from Outperform to Neutral, and lowered the price target from $45.00 to $44.00. In the report, Credit Suisse noted, “Ahead of WTW's earnings report (10/30) and...
-
UPDATE: Credit Suisse Raises PT on AmerisourceBergen Corp. on Multi-Year Growth Outlook
Thursday, July 11, 2013 - 11:21am | 121In a report published Thursday, Credit Suisse analyst Glen Santangelo reiterated an Outperform rating on AmerisourceBergen Corp. (NYSE: ABC), and raised the price target from $61.00 to $64.00. In the report, Credit Suisse noted, “Despite the significant move in the shares YTD (~+31%), we...
-
UPDATE: Credit Suisse Raises PT on Catamaran Following Cigna Partnership Announcement
Tuesday, June 11, 2013 - 11:02am | 121In a report published Tuesday, Credit Suisse analyst Glen Santangelo reiterated an Outperform rating on Catamaran (NASDAQ: CTRX), and raised the price target from $61.00 to $64.00. In the report, Credit Suisse noted, “[Last] evening after the market close, CTRX announced it had signed a 10-year...
-
UPDATE: Credit Suisse Raises PT on Medidata Solutions Following 1Q13 Results
Tuesday, June 4, 2013 - 9:50am | 128In a report published Tuesday, Credit Suisse analyst Glen Santangelo reiterated an Outperform rating on Medidata Solutions (NASDAQ: MDSO), and raised the price target from $75.00 to $80.00. In the report, Credit Suisse noted, “On the back of MDSO's 1Q13 results, continued benefit from...